Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Brucella-Induced Downregulation of lncRNA Gm28309 Triggers Macrophages Inflammatory Response Through the miR-3068-5p/NF-κB Pathway.
Deng X, Guo J, Sun Z, Liu L, Zhao T, Li J, Tang G, Zhang H, Wang W, Cao S, Zhu D, Tao T, Cao G, Baryshnikov PI, Chen C, Zhao Z, Chen L, Zhang H. Deng X, et al. Among authors: tang g. Front Immunol. 2020 Dec 22;11:581517. doi: 10.3389/fimmu.2020.581517. eCollection 2020. Front Immunol. 2020. PMID: 33414782 Free PMC article.
Corrigendum: Brucella-Induced Downregulation of lncRNA Gm28309 Triggers Macrophages Inflammatory Response Through the miR-3068-5p/NF-κB Pathway.
Deng X, Guo J, Sun Z, Liu L, Zhao T, Li J, Tang G, Zhang H, Wang W, Cao S, Zhu D, Tao T, Cao G, Baryshnikov PI, Chen C, Zhao Z, Chen L, Zhang H. Deng X, et al. Among authors: tang g. Front Immunol. 2021 Dec 13;12:805275. doi: 10.3389/fimmu.2021.805275. eCollection 2021. Front Immunol. 2021. PMID: 34966394 Free PMC article.
PRIMARY CUTANEOUS CD8+ AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA WITH NOVEL FGFR1 FUSION TREATED WITH PEMIGATINIB.
Torres-Cabala CA, Yescas J, Zhang Y, Huen A, Gaur S, Tefft K, Tang G, Curry JL, Gunther JR, Dabaja BS, Iyer SP, Miranda RN, Choi J, Nardi V. Torres-Cabala CA, et al. Among authors: tang g. Blood Adv. 2025 Jan 18:bloodadvances.2024014928. doi: 10.1182/bloodadvances.2024014928. Online ahead of print. Blood Adv. 2025. PMID: 39825823 No abstract available.
Clinical Characteristics and Outcomes of Patients Undergoing 3 Aortic Valve Interventions: The THIRD Multicenter Registry.
Tarantini G, Tang GHL, Pilgrim T, Kim WK, Greenbaum A, Castriota F, Webb JG, Nombela Franco L, De Backer O, Hartikainen T, Codner P, Koren O, Patel V, Meier D, Tomii D, Ueyama HA, Paredes-Vázquez JG, Arturi F, Kornowski R, Makkar RR, Cardaioli F, Nai Fovino L; THIRD Registry Investigators. Tarantini G, et al. Among authors: tang ghl. JACC Cardiovasc Interv. 2025 Jan 13;18(1):103-115. doi: 10.1016/j.jcin.2024.10.037. JACC Cardiovasc Interv. 2025. PMID: 39814484
5,207 results